DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer

Table 1 Correlation of DAL-1, E-cadherin, vimentin, snail and clinical pathological characteristics

Clinical pathological characteristics	n	DAL-1					E-cadherin					Vimentin					Snail
Clinical pathological characteristics	n	+++	++	+	-	P	+++	++	+	-	P	+++	++	+	-	P	+++	++	+	-	P
Diameter (cm)
>3	109	16	33	23	37	0.426	13	16	13	67	0.464	9	19	18	63	0.030	50	29	16	14	0.009
≤3	81	10	32	19	20	0.426	7	10	16	48	0.464	2	6	11	62	0.030	21	24	12	24	0.009
Differentiation
Well/mild differentiated	106	18	50	19	19	0.000	16	17	21	52	0.003	0	5	15	86	0.000	36	27	17	26	0.263
Poor differentiated	84	8	15	23	38	0.000	4	9	8	63	0.003	11	20	14	39	0.000	35	26	11	12	0.263
Lymph metastasis
N0	98	22	43	16	17	0.000	12	17	24	45	0.000	0	10	6	82	0.000	24	30	15	29	0.000
N1	92	4	22	26	40	0.000	8	9	5	70	0.000	11	15	23	43	0.000	47	23	13	9	0.000
Pathological stage
I	83	18	39	12	14	0.000	9	14	22	38	0.015	0	8	5	70	0.000	17	25	13	28	0.000
II	57	3	17	18	19		6	6	5	40		4	5	12	36		21	16	13	7
III	42	5	8	9	20		5	5	1	31		5	11	11	15		28	9	2	3
IV	8	0	1	3	4		0	1	1	6		2	1	1	4		5	3	0	0

ISSN: 1756-9966